At the news
? NEUTRALIMPACT 3/10 144 filed Aug 11, 2026 at 17:16 ET
Patrick Burnett, an officer of Arcutis Biotherapeutics, filed a Form 144 on August 11, 2026, indicating intent to sell 15,000 shares of common stock with an approximate market value of $397,824.
- Officer Patrick Burnett filed Form 144 to sell 15,000 shares of ARQT common stock.
- Approximate market value of the proposed sale is $397,824.
- The shares were acquired via stock option exercise on January 12, 2024.
- A prior insider sale of 955 shares occurred on August 3, 2026, for $24,941.54.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access